U-Blot® Research Grade EtesevimabCat. No. WA2824$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade EtesevimabCat. No. WA2824
U-Blot® Research Grade EtentamigCat. No. WA2823
U-Blot® Research Grade EtaracizumabCat. No. WA2822
U-Blot® Research Grade EtanerceptCat. No. WA2821
U-Blot® Research Grade etalanetugCat. No. WA2820
U-Blot® Research Grade Etakafusp AlfaCat. No. WA2819
U-Blot® Research Grade ErzotabartCat. No. WA2818
U-Blot® Research Grade ErtumaxomabCat. No. WA2817
U-Blot® Research Grade ErsodetugCat. No. WA2816
U-Blot® Research Grade ErlizumabCat. No. WA2815
U-Blot® Research Grade ErfonrilimabCat. No. WA2814
U-Blot® Research Grade ErenumabCat. No. WA2813